Research Topics
| G P SwansonSummaryAffiliation: University of Texas Health Science Center Country: USA Publications
| Collaborators |
Detail Information
Publications
Long-term outcome for lymph node-positive prostate cancerG P Swanson
The Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
Prostate Cancer Prostatic Dis 11:198-202. 2008..Length of tumor control depends on the type of treatment given. Adding androgen ablation improves the duration of control dramatically, although optimal timing is still uncertain...- Treatment options in locally advanced prostate cancerG P Swanson
Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
Minerva Urol Nefrol 59:27-42. 2007..In retrospective studies, favorable results have been achieved with dose escalation utilizing intensity modulated external beam radiation therapy or brachytherapy without the need for androgen ablation... - Pathologic findings at radical prostatectomy: risk factors for failure and deathGregory P Swanson
University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA
Urol Oncol 25:110-4. 2007..Therefore, it is important that studies have sufficient follow-up to determine more accurately the risk of failure. We evaluated a large cohort of patients for pathologic findings and risk of failure with a median follow-up of 9.5 years... - Management of locally advanced prostate cancer: past, present, futureGregory P Swanson
Departments of Radiation Oncology and Urology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
J Urol 176:S34-41. 2006..This review explores the continued evolution in the treatment of high risk disease... - Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794Gregory P Swanson
Department of Radiation Oncology and Urology, University of Texas Health Science Center, San Antonio, TX 78229 3900, USA
J Clin Oncol 25:2225-9. 2007..In this analysis, we stratified patients as to their preradiation PSA levels and correlated it with outcomes such as PSA treatment failure, local recurrence, and distant failure, to serve as guidelines for future research... - Treatment options in lymph node-positive prostate cancerGregory P Swanson
Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA
Cancer 106:2531-9. 2006..There have been a few studies with chemotherapy, and no treatment has been proven superior to the others. Consequently, there remain several reasonable alternatives to treatment, and long-term survival is not unusual... - Primary hormone therapy for locally advanced prostate cancerGregory P Swanson
University of Texas Health Science Center, San Antonio, 7703 Floyd Curl Drive, MC 7889, San Antonio, TX 78229, USA
Curr Urol Rep 7:225-32. 2006..The data using this approach are limited, but an understanding of the degree and duration of response is helpful in selecting patients for primary androgen ablation... - Urologists' attitudes regarding cancer clinical researchGregory P Swanson
Department of Radiation Oncology, University of Texas Health Science Center San Antonio, San Antonio, Texas 78229, USA
Urology 70:19-24. 2007..A survey of practicing urologists was undertaken to ascertain their attitudes about prostate cancer research, learn how to increase interest, and lower barriers to their participation... - Adjuvant radiotherapy for high-risk patients following radical prostatectomyGregory P Swanson
Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
Urol Oncol 25:515-9. 2007..These issues have been debated for over 3 decades, but it appears that data are now available to address these questions... - Long-term follow-up of radiotherapy for prostate cancerG P Swanson
Department of Radiation Oncology, Cancer Care Northwest, Spokane, WA 99204, USA
Int J Radiat Oncol Biol Phys 59:406-11. 2004..To determine the long-term outcome of radiotherapy for prostate cancer... - Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated?Edith D Canby-Hagino
Department of Urology, University of Texas Health Sciences Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA
Curr Urol Rep 6:183-9. 2005..This evidence is examined and recommendations are made for identifying patients with metastatic prostate cancer who may benefit from definitive treatment of the prostate tumor... - Current status of lymph node-positive prostate cancer: Incidence and predictors of outcomeGregory P Swanson
Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA
Cancer 107:439-50. 2006..Although the percentage of patients with positive lymph nodes has declined, there remain significant numbers of patients with lymph node-positive prostate cancer, and it remains a therapeutic dilemma... 
The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794Gregory P Swanson
University of Texas Health Science Center, San Antonio, Texas 78229 3900, USA
J Urol 180:2453-7; discussion 2458. 2008..From the randomized study Southwest Oncology Group 8794 we evaluated the effect of seminal vesicle involvement on outcomes and whether those patients benefited from post-prostatectomy adjuvant radiation therapy...- Report from the Radiation Oncology Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2003Paul Okunieff
Department of Radiation Oncology, JP Wilmot Cancer Center, University of Rochester, Rochester, NY 14642, USA
Am J Clin Oncol 26:522-9. 2003..This hypothesis is ready for testing in cancers of the breast, prostate, colon, and in sarcomas. Enlarging the therapeutic window is a major goal that would allow for an increasingly favorable therapeutic gain... - Locally advanced prostate cancer treated with concomitant radiation and 5-fluorouracil: Southwest Oncology Group Study 9024Gregory P Swanson
University of Texas Health Science Center, San Antonio, USA
J Urol 176:548-53; discussion 553. 2006..The modest response rate indicates that better chemotherapy that improves local and systemic failure is necessary to improve the results. This study confirms the feasibility of a combined chemoradiotherapy approach... - Breast conservation in the treatment of breast cancer: community-based experienceG P Swanson
Department of Radiation Oncology, Scott and White Clinic and Memorial Hospital, Texas A and M University System Health Science Center, College of Medicine, Temple, USA
South Med J 94:287-92. 2001..Our findings suggest the successful integration of research-proven innovations into community practice... - A virtual fluoroscopy system to verify seed positioning accuracy during prostate permanent seed implantsV Sarkar
Department of Radiation Oncology, The Cancer Therapy and Research Center at the University of Texas Health Science Center, San Antonio, TX, USA
J BUON 14:447-50. 2009..The purpose of this project was to develop a software platform to produce a virtual fluoroscopic image as an aid for permanent prostate seed implants... - Significance of margins of excision on breast cancer recurrenceGregory P Swanson
Department of Radiation Oncology, Scott and White Hospital, 2401 South 31st Street, Temple, TX 76508, USA
Am J Clin Oncol 25:438-41. 2002..Routine reexcision of patients with positive margins does not significantly increase the chance of local control in patients who receive breast irradiation... - Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinomaCarlos Rodriguez-Galindo
Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, Tennessee 38105, USA
Cancer 103:850-7. 2005..Chemotherapy may help to decrease the radiotherapy dose and limit the side effects of local therapies. However, little is known regarding the chemosensitivity of NPC tumors in pediatric patients... - Failure after primary radiation or surgery for prostate cancer: differences in response to androgen ablationGregory P Swanson
Cancer Care Northwest, Spokane, Washington, USA
J Urol 172:525-8. 2004..If confirmed, this would be a significant consideration for future studies of patients in whom primary therapy fails...